Acessibilidade / Reportar erro

Radioterapia e cirurgia na abordagem do câncer do reto: revisão de literatura, fatores prognósticos e resultados de tratamento

Radiation therapy and surgery in the approach of the rectal cancer: literature revision, prognostic factors and results of treatment

Resumos

O objetivo principal deste estudo foi avaliar os resultados da cirurgia isolada ou associada a radioterapia pré-operatória em pacientes portadores de adenocarcinoma do reto. Foram analisados retrospectivamente 96 pacientes submetidos a cirurgias curativas entre 1972 e 1993. A análise visou, principalmente, comparar as taxas de sobrevida global em cinco anos e de recidiva local. Quarenta e seis pacientes tratados por cirurgias isoladas tiveram taxas de sobrevida em cinco anos e de recidiva local de 51,7% e 26,9%, respectivamente, nos estádios II e III. Cinqüenta pacientes submeteram-se a radioterapia pré-operatória na dosagem de 4.500 cGy, em 25 sessões de 180 cGy, com taxas de sobrevi da em cinco anos e de recidiva local de 60,8% e 18,2%, respectivamente, nos estádios II e III. As diferenças entre os dois grupos terapêuticos não foram estatisticamente significativas. A análise multivariada demonstrou que o estadiamento da neoplasia, principalmente com relação à presença ou não de linfonodos regionais metastáticos, foi o fator prognóstico mais importante, independentemente do grupo terapêutico analisado. Baseados nos resultados apresentados, discutimos que a indicação da radioterapia em câncer do reto deve ser mais seletiva, com realização de cirurgia imediata em pacientes portadores de tumores retais móveis, mesmo infiltrativos na parede, irradiando no pós-operatório apenas os casos com maior risco de recidiva, de acordo com o resultado do exame anatomopatológico da peça cirúrgica. Pacientes portadores de tumores com mobilidade reduzida em relação às paredes pélvicas devem ser irradiados no pré-operatório com a finalidade de facilitação do ato cirúrgico e diminuição do risco de disseminação de células tumorais no intra-operatório e conseqüente diminuição das taxas de recidiva local.

Câncer retal; Adenocarcinoma; Radioterapia; Cirurgia


The main objective of this study was to evaluate the results of surgical treatment alone or associated to preoperative radiation therapy in patients with rectal adenocarcinoma. Ninety-six patients submitted to curative surgeries between 1972 and 1993 were analyzed. The main objective of the statistical analysis was to compare the five-year overall survival and local recurrence rates in patients submitted or not to preoperative radiation therapy. The five-year overall survival and the local recurrence rates for the 46 patients submitted to curative surgery alone, stage II and III, were 51.7% and 26.9%, respectively. The five-year overall survival and the local recurrence rates for the 50 patients submitted to preoperative radiation therapy (25 sessions of 180 cGy - total dose = 4,500 cGy), stage II and III, were 60.8% and 18.2%, respectively. No statistical differences in the five-year overall survival or in the local recurrence rates were observed between the two therapeutic groups. The rectal tumor stage, mainly related to pelvic metastatic lymph nodes, was the most important prognostic factor in the multivariate analysis for all therapeutic groups. Radiation in rectal cancer could be more selective: patients with mobile tumors, even infiltratives, might be submitted to immediate surgery and radiation therapy only in the high risk cases according to the pathological examination. Patients with tethered tumors could be submitted to preoperative radiation therapy due to the high risk for local recurrence.

Rectal cancer; Adenocarcinoma; Radiation therapy; Surgery


ARTIGOS ORIGINAIS

Radioterapia e cirurgia na abordagem do câncer do reto: revisão de literatura, fatores prognósticos e resultados de tratamento

Radiation therapy and surgery in the approach of the rectal cancer: literature revision, prognostic factors and results of treatment

Benedito Mauro Rossi, TCBC-SPI; Wilson Toshihiko NakagawaI; Arno Yukio BorgesI; Wilson Bechara JúniorI; René Aloísio da Costa Vieira, ACBC-SPII; Ademar Lopes, TCBC-SPIII; Luiz Paulo Kowalski, TCBC-SPIV

IMédico Titular

IIDiretor do Departamento de Prevenção e Detecção Precoce do Câncer

IIIDiretor do Departamento de Cirurgia Pélvica

IVDiretor do Departamento de Cirurgia de Cabeça e Pescoço

Endereço para correspondência Endereço para correspondência: Dr. Benedito Mauro Rossi Hospital A. C. Camargo Depto. Cirurgia Pélvica Rua Prof. Antonio Prudente, 211 01509-010 - São Paulo - SP

RESUMO

O objetivo principal deste estudo foi avaliar os resultados da cirurgia isolada ou associada a radioterapia pré-operatória em pacientes portadores de adenocarcinoma do reto. Foram analisados retrospectivamente 96 pacientes submetidos a cirurgias curativas entre 1972 e 1993. A análise visou, principalmente, comparar as taxas de sobrevida global em cinco anos e de recidiva local. Quarenta e seis pacientes tratados por cirurgias isoladas tiveram taxas de sobrevida em cinco anos e de recidiva local de 51,7% e 26,9%, respectivamente, nos estádios II e III. Cinqüenta pacientes submeteram-se a radioterapia pré-operatória na dosagem de 4.500 cGy, em 25 sessões de 180 cGy, com taxas de sobrevi da em cinco anos e de recidiva local de 60,8% e 18,2%, respectivamente, nos estádios II e III. As diferenças entre os dois grupos terapêuticos não foram estatisticamente significativas. A análise multivariada demonstrou que o estadiamento da neoplasia, principalmente com relação à presença ou não de linfonodos regionais metastáticos, foi o fator prognóstico mais importante, independentemente do grupo terapêutico analisado. Baseados nos resultados apresentados, discutimos que a indicação da radioterapia em câncer do reto deve ser mais seletiva, com realização de cirurgia imediata em pacientes portadores de tumores retais móveis, mesmo infiltrativos na parede, irradiando no pós-operatório apenas os casos com maior risco de recidiva, de acordo com o resultado do exame anatomopatológico da peça cirúrgica. Pacientes portadores de tumores com mobilidade reduzida em relação às paredes pélvicas devem ser irradiados no pré-operatório com a finalidade de facilitação do ato cirúrgico e diminuição do risco de disseminação de células tumorais no intra-operatório e conseqüente diminuição das taxas de recidiva local.

Unitermos: Câncer retal; Adenocarcinoma; Radioterapia; Cirurgia.

ABSTRACT

The main objective of this study was to evaluate the results of surgical treatment alone or associated to preoperative radiation therapy in patients with rectal adenocarcinoma. Ninety-six patients submitted to curative surgeries between 1972 and 1993 were analyzed. The main objective of the statistical analysis was to compare the five-year overall survival and local recurrence rates in patients submitted or not to preoperative radiation therapy. The five-year overall survival and the local recurrence rates for the 46 patients submitted to curative surgery alone, stage II and III, were 51.7% and 26.9%, respectively. The five-year overall survival and the local recurrence rates for the 50 patients submitted to preoperative radiation therapy (25 sessions of 180 cGy - total dose = 4,500 cGy), stage II and III, were 60.8% and 18.2%, respectively. No statistical differences in the five-year overall survival or in the local recurrence rates were observed between the two therapeutic groups. The rectal tumor stage, mainly related to pelvic metastatic lymph nodes, was the most important prognostic factor in the multivariate analysis for all therapeutic groups. Radiation in rectal cancer could be more selective: patients with mobile tumors, even infiltratives, might be submitted to immediate surgery and radiation therapy only in the high risk cases according to the pathological examination. Patients with tethered tumors could be submitted to preoperative radiation therapy due to the high risk for local recurrence.

Key words: Rectal cancer; Adenocarcinoma; Radiation therapy; Surgery.

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

Recebido em 25/2/97

Aceito para publicação em 24/11/97

Trabalho realizado no Departamento de Cirurgia Pélvica do Hospital A. C. Camargo - Fundação Antonio Prudente - São Paulo

  • 1
    Ministério da Saúde. INCa/Pró-Onco. Registro Nacional de Patologia Tumoral e Diagnóstico de Câncer - Brasil: 1981-1985. 1991. p.31-64.
  • 2. Freedman GM, Coia LR. Adjuvant and neoadjuvant treatment of rectal cancer. Semin Oncol 1995;22:611-24.
  • 3. Tjandra JJ, Fazio VW. Restorative resection for cancer of the rectum. Hepato-Gastroenterol 1992;39: 195-20 I.
  • 4. Rossi BM, Nakagawa WT, Lopes A. Tratamento cirúrgico do adenocarcinoma do reto em 354 pacientes. Rev Col Bras Cir 1996;23: 197-201.
  • 5. Vivi AA, Lopes A, Cavalcanti SF, et al. Surgical treatment of colon and rectum adenocarcinoma in elderly patients. J Surg Oncol 1992; 51 :203-6.
  • 6. Powers WE, Tolmach LJ. Pre-operative radiation therapy: biological basis and experimental investigation. Nature 1964;201:272-3.
  • 7
    Pilipshen SJ, Heilweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53: 1.354-62.
  • 8
    Hermanek PP, Sobin LH (ed). Classification of malignant tumors (TNM): colorectaI cancer. Berlin, Springer Verlag, 1987. 47p.
  • 9. Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496-502.
  • 10. Moffat FL Jr, Yeung RS, Falk RE, et al. Exenterative surgery for recurrent pelvic neoplasia. Surg Oncol Clin 1994;3:277-90.
  • 11
    Rossi BM, Silva Jr JF, Nakagawa WT, et al. Exenteração pélvica total com preservação esfincteriana: Rev Col Bras Cir 1996;23:167-9.
  • 12
    Stevens KR Jr, Allen CV, Fletcher WS. Preoperátive radiotherapy for adenocarcinoma of the rectosigmoid. Cancer 1976;37:2.866-74.
  • 13. Meade PG, Blatchford GJ, Thorson AG, et al. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J  Surg 1995;170:609-13.
  • 14. Minsky BD. Pelvic radiation therapy in rectal cancer: technical considerations. Semin Radiat Oncol 1993;3:42-7.
  • 15. Tominaga T, SakabeT, Koyama Y, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only: five-year follow report. Cancer 1996;78:403-8.
  • 16
    Roswit B, Higgins GA, Keerhn RJ. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration Randomized Study. Cancer 1975;35: 1.597-602.
  • 17. Rider WD, Palmer JA, Mahoney LJ, et al. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J  Surg 1977;20:335-8.
  • 18
    Cedermark B, Johansoon H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1995;75: 2.269-75.
  • 19. De Leon MP, Sant M, Micheli A, et al. Clinical and pathologic prognostic indicators in colorectal cancer: a population-based study. Cancer 1992;69:626-35.
  • 20. Hermanek PP, Guggenmoos-Holzmann I, Gall FP. Prognostic factors in rectal carcinoma: a contribution to the further development of tumor classification. Dis Colon Rectum 1989;32:593-9.
  • 21. Wiggers T, Arends JW, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988;31:33-41.
  • 22. Mohiuddin M, Regine WF, Marks G. Prognostic significance of tumor fixation of  rectal carcinoma. Cancer 1996;78:717-22.
  • 23
    Fazio VW. Cancer of the rectum: sphincter-saving operation. Surg Clin North Am 1988;68:1.367-81.
  • 24. Rossi BM, Nakagawa WT, Lopes A. Cirurgias de preservaçăo esfincteriana com utilizaçăo de anastomoses mecânicas em câncer retal. Rev Col Bras Cir 1995;22:258-62.
  • 25. Gentil FC, Lopes A, SÁ AOS, et al. Ressecçăo ampliada no tratamento do câncer avançado do cólon. Rev Bras Colo-Proctol 1989;9: 93-101.
  • 26
    NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264: 1.444-50.
  • 27. SRCSG - Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1990;66:49-55.
  • 28
    Cedermark B. The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma - a prospective randomized trial. Proc ASCO 1994;13:198. [abstract]
  • 29
    Holm T, Rutqvist E, Johansson H, et al. Abdominoperineal resection and anterior resection in the treatment of rectal cancer: results in relation to adjuvant preoperative radiotherapy. Br J  Surg 1995; 82: 1.213-6.
  • 30. Marsh PJ, James RD, Schofield PF. Definition of local recurrence after surgery for rectal carcinoma. Br J  Surg 1995;82:465-8.
  • 31. MRC Working Party. Second Report: The evaluation of low dose pre-operative x-ray therapy in the management of operable rectal cancer; results of a randomly controlled trial. Br J Surg 1984;71 :21-5.
  • 32. Higgins GA, Humphrey EW, Dwight RW, et al. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer 1986;58:352-9.
  • 33. Gérard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208:606-14.
  • 34
    Dahl O, Horn A, Morild I. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Cancer 1990;66:2.286-94.
  • 35. Reis Neto JA, Quilici FA, Reis Jr JA. A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma: a 10-year randomized trial. Dis Colon Rectum 1989;32:702-10.
  • 36. Dwight RW, Higgins GA, Roswit B, et al. Preoperative radiation and surgery for cancer of the sigmoid colon and rectum. Am J Surg 1972; 123:93-103.
  • 37
    MRC Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potencially operable locally advanced rectal cancer. Lancet 1996;348:1.605-10.
  • 38
    MRC Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996;348:1.610-14.
  • 39
    Marks G, Mohiuddin M, Goldstein SO. Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation. Int J Radiol Oncol Biol Phys  1988;15:1.065-8.
  • 40. Mendenhall WM, Bland KI, Rout WR, et al. Clinically resectable adenocarcinoma of the rectum treated with preoperative irradiation and surgery. Dis Colon Rectum 1988;31:287-90.
  • 41. Reed WP, Garb JL, Park WC, et al. Long-term results and complications of preoperative radiation in the treatment of rectal cancer. Surgery 1988;103:161-7.
  • 42. Kodner IJ, Shemesh EI, Fry RD, et al. Preoperative irradiation for rectal cancer: improved local control and long-term survival. Ann Surg 1989;209:194-9.
  • 43
    Sarashina H, Todoroki T, Orii K, et al. Effects of preoperative radiotherapy on rectal cancer: preliminary report on combining radiation with intratumor injections of peplomycin and bromo-deoxyuridine. Dis Colon Rectum 1990;33:1.017-25.
  • 44. Berard P, Papillon J. Role of pre-operative irradiation for anal preservation in cancer of the low rectum. World J Surg 1992;16:502-9.
  • 45. Mohiuddin M, Marks G. Patterns of recurrence following high-dose preoperative radiation and sphincter-preserving surgery for cancer of the rectum. Dis Colon Rectum 1993;36: 117 -26.
  • 46. Rossi BM, Nakagawa WT, Fogaroli RC, et al. Adenocarcinoma do reto: abordagem multidisciplinar em 43 casos. Acta Oncol Bras 1995; 15:220-3.
  • Endereço para correspondência:

    Dr. Benedito Mauro Rossi
    Hospital A. C. Camargo
    Depto. Cirurgia Pélvica
    Rua Prof. Antonio Prudente, 211
    01509-010 - São Paulo - SP
  • Datas de Publicação

    • Publicação nesta coleção
      05 Ago 2010
    • Data do Fascículo
      Abr 1998

    Histórico

    • Aceito
      24 Nov 1997
    • Recebido
      25 Fev 1997
    Colégio Brasileiro de Cirurgiões Rua Visconde de Silva, 52 - 3º andar, 22271- 090 Rio de Janeiro - RJ, Tel.: +55 21 2138-0659, Fax: (55 21) 2286-2595 - Rio de Janeiro - RJ - Brazil
    E-mail: revista@cbc.org.br